Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 13/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.46 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.46 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10602703 | 0.89 | GPR35 (0.55) | VCAM1ALDH1A1MAPK1HPGDTDP1 | |
| SCHEMBL12591651 | 0.86 | VCAM1 (0.53) | VCAM1ALDH1A1MAPK1HPGDTSHR | |
| SCHEMBL10907199 | 0.83 | VCAM1 (0.53) | VCAM1ALDH1A1MAPK1HPGDTDP1 | |
| SCHEMBL6222813 | 0.82 | TSHR (0.55) | ALDH1A1NPC1GLAMAPK1CASP3 | |
| SCHEMBL6821981 | 0.82 | VCAM1 (0.53) | VCAM1ALDH1A1NPC1GLAMAPK1 | |
| SCHEMBL140068 | 0.81 | ALDH1A1 (0.65) | VCAM1ALDH1A1MAPK1HPGDTDP1 | |
| SCHEMBL7218755 | 0.81 | TDP1 (0.55) | VCAM1ALDH1A1MAPK1HPGDTDP1 | |
| SCHEMBL4089390 | 0.79 | NPC1 (0.60) | ALDH1A1NPC1GLAMAPK1CASP3 | |
| SCHEMBL13945797 | 0.79 | ALDH1A1 (0.50) | ALDH1A1NPC1GLAMAPK1CASP3 | |
| SCHEMBL29588338 | 0.79 | NPC1 (0.60) | ALDH1A1NPC1GLAMAPK1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12391663-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-19 | — | — | US | disclosed |
| US-20240261274-A1 | TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-08-08 | — | — | US | disclosed |
| CN-117924041-A | Method for preparing high-purity m-tertiary butyl phenol by layered melt crystallization | 天津科技大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117886674-A | Synthesis method of m-tert-butylphenol | 蔚源生物科技(平顶山)有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240083869-A1 | ISOINDOLINONE COMPOUNDS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-03-14 | — | — | US | disclosed |
| US-11912682-B2 | Isoindolinone compounds | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117242060-A | Isoindolinone compounds | 蒙特罗萨医疗公司 | 2023-12-15 | — | — | CN | disclosed |
| US-20230348418-A1 | ISOINDOLINONE COMPOUNDS | MONTE ROSA THERAPEUTICS AG (CH) | 2023-11-02 | — | — | US | disclosed |
| US-20230288804-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-14 | — | — | US | disclosed |
| CN-108383689-B | A kind of preparation method of 3,5- DI-tert-butylphenol compounds | 江苏极易新材料有限公司 | 2019-03-26 | — | — | CN | disclosed |
| US-7189501-B2 | Silver halide color photographic photosensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20070037794-A1 | 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides | CHEMOCENTRYX, INC. | 2007-02-15 | — | — | US | disclosed |
| US-7125988-B2 | Dye-forming coupler and silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2006-10-24 | — | — | US | disclosed |
| US-6887657-B2 | Silver halide color photographic photosensitive material and image-forming method | FUJI PHOTO FILM CO., LTD. (JP) | 2005-05-03 | — | — | US | disclosed |
| US-20050074710-A1 | Silver halide color photographic photosensitive material | FUJI PHOTO FILM CO., LTD. | 2005-04-07 | — | — | US | disclosed |
| US-20040234908-A1 | Silver halide color photographic photosensitive material and image-forming method | FUJI PHOTO FILM CO., LTD. | 2004-11-25 | — | — | US | disclosed |
| EP-1403704-A1 | Dye-forming coupler and silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-4133673-A | HERBICIDES | UNITED STATES BORAX & CHEMICAL CORPORATION (US) | 1979-01-09 | — | — | US | disclosed |
| US-4133672-A | (Aminophenyl)morpholines and use thereof | UNITED STATES BORAX & CHEMICAL CORPORATION (US) | 1979-01-09 | — | — | US | disclosed |
| US-4094662-A | HERBICIDES | UNITED STATES BORAX & CHEMICAL CORPORATION (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037794-A1 | 4-((5-Chloro-3-(4-methyl-3-trifluoromethylbenzenesulfonylamino)pyridin-2-yl)-oxo-)1H-pyrrolo(2,3-)pyridine;interfere with ligand (monocyte chemoatactic protein-1) for chemokine receptors (CCR2); antiinflammatory agents; immunomodulators; bactericides; viricides; fungicides | CCR2, CCR1, CCL2 | VCAM1 47/4885ALDH1A1 1867/4885NPC1 3061/4885 |
| US-12391663-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | VCAM1 4379/4885ALDH1A1 1142/4885NPC1 285/4885 |
| US-20240083869-A1 | ISOINDOLINONE COMPOUNDS | CYP4F2, AOC2, AOC3 | VCAM1 4379/4885ALDH1A1 1142/4885NPC1 285/4885 |
| US-20230348418-A1 | ISOINDOLINONE COMPOUNDS | CYP4F2, AOC2, AOC3 | VCAM1 4452/4885ALDH1A1 1370/4885NPC1 269/4885 |
| US-11912682-B2 | Isoindolinone compounds | CYP4F2, AOC2, AOC3 | VCAM1 4379/4885ALDH1A1 1142/4885NPC1 285/4885 |
| US-20240261274-A1 | TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS | MYC, MYCBP, GSPT1 | VCAM1 3385/4885ALDH1A1 4276/4885NPC1 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.